<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140708018409N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-23</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of microcurrent device and exercise therapy in the treatment of patients with Tennis Elbow disease</public_title>
      <acronym></acronym>
      <scientific_title>Comparison effectiveness of microcurrent  and exercise therapy on the pain and function in patients with Lateral Epicondylitis(Tennis Elbow disease)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54109</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Clinical trial without control group, with parallel groups, one-way blind, randomized, Randomization description: There are two envelopes with names A and B, including microcurrent and exercise therapy group, inside the container and the patient chooses one.
 The selected envelope is then inserted into the container and the next patient selects one again, Blinding description: Considering that the patient knows in which group (exercise therapy or microcurrent  therapy  ) but the evaluator (supervisors) do not know which patient is in which group and all follow-ups are done by the sports medicine assistant and the evaluator only reviews the results It deals with questionnaires and recorded values of manual dynamometer, so this study is one-way blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Lateral Epicondylitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1:Exercise therapy:In this study, exercise therapy protocol was designed in a 6-week period of exercise to strengthen the elbow muscles focusing on the extensor muscles of the forearm involved in the pathology of lateral epicondylitis.Exercise sessions for 6 weeks 3 sessions per week according to the patient's tolerance based on the VAS scale are performed under the supervision of a sports medicine assistant at the clinic.Interventions including range of motion exercises, isometric, isotonic and eccentric exercises can be performed in three sets of 15 repetitions according to the patient's tolerance up to the experience of mild pain (4: VAS). Rest between sets will be 1-2 minutes.If the patient mentions debilitating pain (VAS: 8), the exercise is stopped and its intensity is recorded and it is performed with less intensity in the next sessions.When the patient reaches VAS: 0 in painless exercises, the intensity of the exercises is improved by using weights up to half a kilogram.Stretching exercises are performed in the form of static stretching performed by the patient him/herself with the support of the other hand. 6 stretches divided into 2 sets of 3 stretches are done at the beginning and end of exercise therapy with a time of 30 to 45 seconds of stretching and 30 seconds of rest between stretches. Intervention 2: Intervention group 2: In this study,microcurrent interventionn by NU-TEK MT8000 COMBO STIMULATOR portable microcurrent device made in China for 6 weeks and 3 sessions of 15 minutes every week under 70 μA current at the origin of the extensor muscles in the external epicondyle of the hand will be done.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
results of statistical analysis and its analysis

When:
Start of access 12 months after printing results

To whom:
Health researchers

Conditions:
view data

Where to obtain:
corresponding author

How to obtain:
About 2 months

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Gholamreza Partovi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Khomeyni Hospital, Amir Mazandarani Ave</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816633131</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>ghpartovi@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Gholamreza Partovi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Khomeyni Hospital, Amir Mazandarani Ave</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816633131</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>ghpartovi@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients with Lateral Epicondylitis in the age range of 18 to 60 years who do not  have criteria for not entering the interventions</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any contraindications to the use of microcurrent therapy, including: epilepsy, diabetes, immune system disorders, cancer, melanoma, metal implants (plates, pins, and screws) at the treatment site, open wounds, pacemaker, phlebitis, thrombosis , embolism, varicose veins and pregnancy
Any history of shoulder or elbow fractures or history of dislocations in these areas during the past year
Any history of shoulder and elbow surgery during the last six months
Any phobias about treatment and suffer from chronic psychiatric disorders
Any allergies and contraindications to the use of NSAIDs
Any history of cervical discopathy confirmed by imaging and sensory-motor involvement  symptoms (paresthesia) in the upper limb</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M77.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Lateral epicondylitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1:Exercise therapy:In this study, exercise therapy protocol was designed in a 6-week period of exercise to strengthen the elbow muscles focusing on the extensor muscles of the forearm involved in the pathology of lateral epicondylitis.Exercise sessions for 6 weeks 3 sessions per week according to the patient's tolerance based on the VAS scale are performed under the supervision of a sports medicine assistant at the clinic.Interventions including range of motion exercises, isometric, isotonic and eccentric exercises can be performed in three sets of 15 repetitions according to the patient's tolerance up to the experience of mild pain (4: VAS). Rest between sets will be 1-2 minutes.If the patient mentions debilitating pain (VAS: 8), the exercise is stopped and its intensity is recorded and it is performed with less intensity in the next sessions.When the patient reaches VAS: 0 in painless exercises, the intensity of the exercises is improved by using weights up to half a kilogram.Stretching exercises are performed in the form of static stretching performed by the patient him/herself with the support of the other hand. 6 stretches divided into 2 sets of 3 stretches are done at the beginning and end of exercise therapy with a time of 30 to 45 seconds of stretching and 30 seconds of rest between stretches.</i_keyword>
      <i_keyword>Intervention group 2: In this study,microcurrent interventionn by NU-TEK MT8000 COMBO STIMULATOR portable microcurrent device made in China for 6 weeks and 3 sessions of 15 minutes every week under 70 μA current at the origin of the extensor muscles in the external epicondyle of the hand will be done.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Patient-Rated Tennis Elbow Evaluation questionnaire (PRTEE). Timepoint: Before the beginning and end of the intervention (sixth week) and 12 weeks after the end of the intervention. Method of measurement: Measurements are performed based on the values obtained from PRTEE questionnaire.</prim_outcome>
      <prim_outcome>Visual Analog Scale For Pain(VAS). Timepoint: Before the beginning and end of the intervention (sixth week) and 12 weeks after the end of the intervention. Method of measurement: Measurements are performed based on the values obtained from VAS questionnaire.</prim_outcome>
      <prim_outcome>Handheld dynamometer. Timepoint: Before the beginning and end of the intervention (sixth week) and 12 weeks after the end of the intervention. Method of measurement: Measurements are performed based on the values obtained from  Handheld dynamometer .</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-24</approval_date>
        <contact_name>Ethics committee of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Vice chancellor for research Mazandaran University of Medical Sciences, Moalem Square, Moalem Street Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
